Bayer Should Stress Clot Risk On Yaz Label: FDA Panel
A U.S. Food and Drug Administration panel reportedly recommended Thursday that Bayer AG revise the labels on its Yaz and Yasmin contraceptives to highlight increased blood clot risks associated with the...To view the full article, register now.
Already a subscriber? Click here to view full article